To test whether inhibition of eIF5A activity reduces cardiac fibrosis, we treated the MI mouse model with a deoxyhypusine hydroxylase inhibitor CPX after the MI surgery (4 h post-MI) for 14 consecutive days (Figure 2A). Here, EIF5A is linked to myocardial infarction.